All In Biotech

Drug Trial Radar · NCT05781152

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

Last checked: Nov 20, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

1,270

Actual

Start

Jun 10, 2023

Primary completion

Jul 1, 2028

Study completion Jul 1, 2029

Sponsor

Lead sponsor
Connecticut Children's Medical CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Emory University; Children's Hospital Medical Center, Cincinnati; University of North Carolina, Chapel Hill
First posted
Mar 23, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 6 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Crohn's disease (CD) is a condition that causes inflammation (swelling, redness) of the lining and wall of the small intestine, large intestine, or both. CD may be associated with abdominal cramps/pain, diarrhea, blood in the stool, weight loss, or delayed growth in children. While the exact cause of CD is not certain it is thought that the immune system located in the intestine reacts abnormally to the large number of bacteria contained there. The investigators think that diet, exposure to antibiotics early in life, and having a family history of CD puts people at increased risk for developing CD. In order to decrease the inflammation doctors use what is called biologic therapy with anti-TNF molecules that can be given through an intravenous or shots. TNF is a chemical made by white blood cells that is involved in inflammation. When this type of treatment is given early after diagnosis it is more effective than when it is given later. The investigators have learned that it is important to give the optimum (ideal) amount of this medicine guided by certain blood tests. The investigators also know that not everyone responds to this therapy but do not understand the reasons for this variability between people. The CAMEO study has been started to help understand what factors are important in determining whether a child with CD completely heals the inflammation after anti-TNF therapy. The investigators will do that by measuring certain markers of inflammation in the blood and stool and by looking at a person's genes (DNA) and how inflammation is controlled in the intestine. These inflammation tests will be done before, during, and after one year of anti-TNF therapy. The investigators will determine how much healing has taken place by comparing the results of the colonoscopy and a special type of MRI that are both done before anti-TNF and then again one year later. The goal in treating CD is to heal both the lining and the wall of the intestine. Children ages 6-17 years who are thought to have CD and are about to undergo their diagnostic colonoscopy are eligible to be enrolled. If they are found to indeed have CD and start an anti-TNF medicine within 6 months they can continue in the study. There are no increased risks of participating in this study beyond those normally associated with having CD and its treatment. By better understanding why the bowel does or does not heal, doctors will be better able to provide personalized care.

Conditions

  • Crohn Disease

Interventions

  • Anti-TNF therapyDrug

    Use of anti-TNF therapy for children and adolescents with newly diagnosed Crohn's disease guided by a clinical decision support tool

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Complete healing (CH)Time frame: 52 weeks from anti-TNF start

Locations

26 sites in 2 countries. Site status is shown where the registry gives one.

  • Phoenix Children's Hospital

    Phoenix, Arizona

  • Cedars-Sinai

    Los Angeles, California

  • Rady Children's Hospital - San Diego and University of California, San Diego

    San Diego, California

  • UCSF Benioff Children's Hospitals

    San Francisco, California

  • Connecticut Children's Medical Center

    Hartford, Connecticut

  • Emory University

    Atlanta, Georgia

  • Riley Hospital for Children at Indiana University Health

    Indianapolis, Indiana

  • The Johns Hopkins Children's Medical Center

    Baltimore, Maryland

  • Boston Children's Hospital

    Boston, Massachusetts

  • University of Michigan

    Ann Arbor, Michigan

  • Goryeb Children's Hospital/Morristown Medical Center/Atlantic Children's Health

    Morristown, New Jersey

  • Cohen Children's Medical Center of NY

    Lake Success, New York

  • Columbia University Medical Center

    New York, New York

  • Levine Children's

    Charlotte, North Carolina

  • Cincinnati Children's Hospital Medical Center

    Cincinnati, Ohio

  • UH/Rainbow Babies and Children's Hospital

    Cleveland, Ohio

  • Nationwide Children's Hospital

    Columbus, Ohio

  • Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania

  • UPMC Children's Hospital of Pittsburgh

    Pittsburgh, Pennsylvania

  • Rhode Island Hospital

    Providence, Rhode Island

  • Seattle Children's Hospital

    Seattle, Washington

  • Medical College of Wisconsin

    Milwaukee, Wisconsin

  • Stollery Children's Hospital

    Edmonton, Alberta, Canada

  • Children's Hospital Western Ontario

    London, Ontario, Canada

  • Children's Hospital of Eastern Ontario

    Ottawa, Ontario, Canada

  • Toronto SickKids Hospital

    Toronto, Ontario, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.